Hemispherx Biopharma Files NDA for Ampligen – FDA news (subscription)

by General Manager on 12th October 2007

in All ME/ Chronic Fatigue Syndrome And Fibromyalgia News

Hemispherx Biopharma Files NDA for Ampligen

FDA news, VA -

Hemispherx Biopharma has filed a new drug application (NDA) with the FDA for Ampligen, its experimental therapeutic to treat chronic fatigue syndrome. …

Source: FDA news

Leave a Comment

Previous post: HEALTH BRIEFS – USA Weekend

Next post: BC woman laughs in the face of her disorder – Battle Creek Enquirer